Boc-L-beta-HArg(Tos)-OH

Boc-L-beta-HArg(Tos)-OH is a Boc-protected L-β-homoarginine derivative bearing a tosyl-protected side-chain guanidinium group. This protected amino acid building block is designed for controlled incorporation into peptide sequences where the extended β-homoarginine side chain and protected cationic functionality must remain stable during coupling and deprotection steps. As a research-grade, protected amino acid, it is commonly selected for peptide synthesis workflows that require orthogonal handling of the guanidinium functionality and reliable segment assembly.

1. Solid-Phase Peptide Synthesis

Boc-L-beta-HArg(Tos)-OH is frequently used by peptide synthesis groups to assemble peptides that contain β-homoarginine residues while minimizing side reactions from the strongly basic guanidinium side chain. The Boc group provides N-terminal protection for stepwise coupling, while the tosyl (Tos) protection on the side-chain guanidinium helps maintain compatibility with standard peptide assembly conditions and downstream deprotection strategies. This makes the building block a practical choice for custom peptide synthesis and peptide library construction where sequence-defined incorporation of a basic, extended side chain is required for charge patterning and structure-function studies.

2. Modified Peptide Development

Boc-L-beta-HArg(Tos)-OH supports the development of modified peptides for chemical biology and medicinal chemistry research, particularly when researchers need to introduce a β-homoarginine motif to tune local charge density, spacing, and electrostatic interactions relative to canonical arginine. The protected guanidinium functionality helps preserve the intended side-chain chemistry during synthesis, enabling later functionalization or controlled unmasking as part of a defined workflow. Laboratories using this reagent typically focus on structure-activity relationship studies, receptor/ligand interaction mapping, and stability or binding assays that depend on precise placement of a basic residue within a peptide scaffold.

3. Pharmaceutical Intermediate Building Block

Boc-L-beta-HArg(Tos)-OH is also used in pharmaceutical intermediate development where protected amino acid derivatives serve as reliable inputs for manufacturing-oriented synthesis of peptide-like intermediates. The combination of N-Boc protection and Tos-protected side-chain guanidinium provides a robust, isolable handle for sequential transformations and purification during intermediate preparation. Process chemistry and CMC-focused teams commonly select this type of protected building block to reduce variability from side-chain reactivity and to streamline the assembly of defined, sequence-specific intermediates used in downstream synthesis of larger peptide constructs.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

3. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

4. Implications of ligand-receptor binding kinetics on GLP-1R signalling

5. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes